PharmaTelevision Launches New Premium Content Service

PharmaTelevision Launches New Premium Content Service

OXFORD, England, July 15/PRNewswire/ --

- Senior Executives at Pfizer, Johnson & Johnson, GlaxoSmithKline, and
Other Big Pharma use New Media to Bring Fresh Exchange

PharmaTelevision, the authoritative channel for the pharmaceutical,
biotechnology and related industries, announced today the launch of its new
service, PharmaTelevision Premium Content. PTV Premium Content will include
PTV News - a daily news and analysis service to be launched in August.
Subscription to the service will be free until 30 September, 2009. Dr Fintan
Walton, CEO of PharmaVentures - the company behind PharmaTelevision - said,
"Television captures and delivers something unique, recognising that business
is ultimately about the people in it - whether it's a part of deal making, or
discovery and development, or about a company's ability to finance itself.
It's not a surprise to us that PharmaTelevision has become 'must view' TV for
many senior executives and managers".

Dr Walton continues, "Launch of this new service means we can deliver to
our subscribers great television programming and integrated news and analysis
information services." PharmaTelevision addresses the current issues and
future predictions of the industry, including those of the top companies,
through news, analysis, interviews, panels and discussions. Interviewees come
from companies such as Johnson & Johnson, Merck & Co., sanofi-aventis,
Genzyme, MerckSerono, NICE UK, and Roche. As well as PTV News, current
programmes include PharmaVentures Business Review; The Regional Report; The
Financial Report; and PharmaDeals(R) Commentaries, and bring the major
industry players straight to desktops - on demand from the viewer.

Dr Walton says, "This year, development to PharmaTelevision has been
rapid as we meet the demand from our discerning audience. Our subscribers can
look forward to significant upgrades that help them uncover further value in
the service, and not least will shortly see news services compiled jointly by
top experts from both the pharmaceutical and the television world.
Subscribers to PharmaTelevision Premium Content can access over 200 high
quality interviews and panel discussions filmed since June 2006. Dr Walton
concludes, "It's an exciting time for us and our viewers."

About PharmaTelevision(R)

PharmaTelevision (http://www.pharmatelevision.com) is the groundbreaking
online TV channel for the pharmaceutical and biotech sector, offering
insight, featured interviews, panel discussions and company information.
Since May 2006, PharmaTelevision has rapidly grown and the channel now boasts
over 200 TV programmes with a truly global audience, 60% of whom are C-suite
executives. In 2008, the channel launched a sleek new look and introduced two
exciting TV programmes - the Financial Report and the Regional Report, which,
together with our well-established TV programmes, help to give our viewers a
complete overview of industry trends, analysis including deals, investments
and strategic policies within the sector. In 2009, PharmaTelevision will be
launching PTV News - a daily summary and analysis of the major news
headlines, ensuring that, wherever in the world they are, our audience can
stay truly informed.

Testimonials about the value of PharmaTelevision from industry leading
figures can be viewed online at
http://www.pharmatelevision.com/VideoHandler.aspx?ID=166&Type=flv

A promotional Video about PharmaTelevision can be viewed online at:
http://www.pharmatelevision.com/VideoHandler.aspx?ID=270

PharmaTelevision is a part of the business media division of
PharmaVentures Ltd (http://www.pharmaventures.com).

Notes to Editors:

About PharmaVentures

A leading results driven organisation, PharmaVentures (
http://www.pharmaventures.com) assists pharmaceutical and biotechnology
companies across the world in all aspects of deal making and business
intelligence. The Company's provides tailored consulting and transaction
advisory services to the Life Science industry, with additional deal making
support provided through the PharmaDeals range of intelligence products that
include analysis tools and reports. An innovative business, PharmaVentures
additionally provides industry insight through the world's first dedicated
online pharmaceutical television channel http://www.pharmatelevision.com.

Now in its 17th year PharmaVentures is based in Oxford, UK, employs over
50 people mostly educated to PhD or above, and has increased its turnover
five fold with 80% of revenues from outside the UK. With offices in the USA
and Australia, the Company works for a variety of clients from start-ups to
global corporate pharmaceutical companies.

For further information, or to receive a demonstration of the new
service, please contact:

Lisa Holloway
Marketing, PharmaTelevision
+44-(0)1865-784-177
lisa.holloway@pharmaventures.com

Fintan Walton,
+44-(0)1865-784-187
fintan.walton@pharmaventures.com

Source: PharmaVentures

For further information, or to receive a demonstration of the new service, please contact: Lisa Holloway, Marketing, PharmaTelevision, +44-(0)1865-784-177, lisa.holloway@pharmaventures.com. Fintan Walton, +44-(0)1865-784-187 fintan.walton@pharmaventures.com

-------
Profile: intent